JRM
Journal of Radiology in Medicine

Journal of Radiology in Medicine is an international journal that published original research and articles in all areas of radiology. Its publishes original research articles, review articles, case reports, editorial commentaries, letters to the editor, educational articles, and conference/meeting announcements.

eISSN: 3023-6487
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Original Article
Integration of CT radiomics and clinical factors to predict pathological response to FLOT chemotherapy in gastric cancer
Abstract
Aims: Neoadjuvant chemotherapy (NAC) has become a standard of care for locally advanced gastric cancer (LAGC), but a significant portion of patients do not respond to treatment, leading to unnecessary toxicity and delayed definitive surgery. Non-invasive, predictive tools are urgently needed to identify these non-responders prior to treatment. This study aimed to develop and validate a predictive model using an integrated approach of clinical factors and radiomic features extracted from pre-treatment computed tomography (CT) scans to classify LAGC patients as responders or non-responders to the neoadjuvant FLOT protocol.
Methods: This retrospective study utilized 163 patients. A comprehensive feature set, including 11 patient biomarkers and 101 radiomic features, was used to train various machine learning algorithms via the pyCaret library. The Light Gradient Boosting Machine (LightGBM) was identified as the top-performing model.
Results: On the internal validation, the LightGBM model achieved an accuracy of 80% with an AUC of 0.7926. Key features contributing to the model’s prediction included albumin, CA 19-9, age, and specific radiomic features such as Robust Mean Absolute Deviation. However, the model’s performance decreased in the independent external validation, yielding an accuracy of 54.59% and an AUC of 0.5409, highlighting challenges in generalizability.
Conclusion: This study demonstrates the potential of an integrated clinical and radiomic approach using a LightGBM model to non-invasively predict treatment response to FLOT in LAGC. While the model showed strong internal performance, the decreased performance on an external validation set underscores the critical need for larger, multi-institutional, prospective studies with standardized data collection to establish clinical generalizability and widespread utility.

Keywords : Gastric cancer, neoadjuvant chemotherapy, FLOT protocol, radiomics, predictive model, CT scans, treatment response, machine learning

Download Article


1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249. doi: 10.3322/caac.21660
2. Ajani JA, D’Amico TA, Bentrem DJ, et al. Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022; 20(2):167-192. doi:10.6004/jnccn.2022.0008
3. Al-Batran SE, Homann N, Pauligk C, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet. 2019; 393(10184):1948-1957. doi:10.1016/S0140-6736(18)32557-1
4. van Laarhoven H. Management of locally advanced gastric cancer. Lancet Oncol. 2025;26(3):267-269. doi:10.1016/S1470-2045(24)00727-7
5. Paszt A, Simonka Z, Budai K, et al. Impact of neoadjuvant FLOT treatment of advanced gastric and gastroesophageal junction cancer following surgical therapy. Front Surg. 2023;10:1148984. doi:10.3389/fsurg.2023.1148984
6. Sun F, Gao X, Wang W, Zhao X, Zhang J, Zhu Y. Predictive biomarkers in the era of immunotherapy for gastric cancer: current achievements and future perspectives. Front Immunol. 2025;16:1599908. doi:10.3389/fimmu.2025.1599908
7. Zhou H, Gu Q, Bao R, et al. Machine learning based models for predicting presentation delay risk among gastric cancer patients. Front Oncol. 2025;14:1503047. doi:10.3389/fonc.2024.1503047
8. Zubarayev M, Min EK, Son T. Clinical and molecular prognostic markers of survival after surgery for gastric cancer: tumor-node-metastasis staging system and beyond. Transl Gastroenterol Hepatol. 2019;4:59. doi:10.21037/tgh.2019.08.05
9. Kuhl CK, Alparslan Y, Schmoee J, et al. Validity of RECIST version 1.1 for response assessment in metastatic cancer: a prospective, multireader study. Radiology. 2019;290(2):349-356. doi:10.1148/radiol.2018180648
10. Chan AK, Wong A, Jenken D, Heine J, Buie D, Johnson D. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys. 2005;61(3):665-677. doi:10. 1016/j.ijrobp.2004.06.206
11. Lowy AM, Mansfield PF, Leach SD, Pazdur R, Dumas P, Ajani JA. Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer. Ann Surg. 1999;229(3):303-308. doi: 10.1097/00000658-199903000-00001
12. Chen YH, Xiao J, Chen XJ, et al. Nomogram for predicting pathological complete response to neoadjuvant chemotherapy in patients with advanced gastric cancer. World J Gastroenterol. 2020;26(19):2427-2439. doi:10.3748/wjg.v26.i19.2427
13. Sun KY, Hu HT, Chen SL, et al. CT-based radiomics scores predict response to neoadjuvant chemotherapy and survival in patients with gastric cancer. BMC Cancer. 2020;20(1):468. doi:10.1186/s12885-020-06970-7
14. Adili D, Mohetaer A, Zhang W. Diagnostic accuracy of radiomics-based machine learning for neoadjuvant chemotherapy response and survival prediction in gastric cancer patients: a systematic review and meta-analysis. Eur J Radiol. 2024;173:111249. doi:10.1016/j.ejrad.2023.111249
15. Song R, Cui Y, Ren J, et al. CT-based radiomics analysis in the prediction of response to neoadjuvant chemotherapy in locally advanced gastric cancer: a dual-center study. Radiother Oncol. 2022;171: 155-163. doi:10. 1016/j.radonc.2022.04.023
16. Wang HN, An JH, Wang FQ, Hu WQ, Zong L. Predicting gastric cancer survival using machine learning: a systematic review. World J Gastrointest Oncol. 2025;17(5):103804. doi:10.4251/wjgo.v17.i5.103804
17. Akcay M, Etiz D, Celik O. Prediction of survival and recurrence patterns by machine learning in gastric cancer cases undergoing radiation therapy and chemotherapy. Adv Radiat Oncol. 2020;5(6):1179-1187. doi:10.1016/j.adro.2020.07.007
18. Wang W, Sheng R, Liao S, et al. LightGBM is an effective predictive model for postoperative complications in gastric cancer: a study integrating radiomics with ensemble learning. J Imaging Inform Med. 2024;37(6):3034-3048. doi:10.1007/s10278-024-01172-0
19. Wang S, Zheng G, Cheng B, et al. Circulating tumor cells (CTCs) detected by RT-PCR and its prognostic role in gastric cancer: a meta-analysis of published literature. PLoS One. 2014;9(6):e99259. doi:10. 1371/journal.pone.0099259
20. Sun C, Niu P, Zhang X, et al. Concurrent clinical and pathological response predicts favorable prognosis of patients with gastric cancer after neoadjuvant therapy: a real-world study. BMC Cancer. 2023;23(1): 996. doi:10.1186/s12885-023-11508-8
21. D’Alessio A, Lombardi P, Stefanini B, et al. Use of pathological response versus RECIST assessment in predicting relapse-free survival following neoadjuvant immunotherapy for hepatocellular carcinoma. Meeting Abstract: 2025 ASCO Gastrointestinal Cancers Symposium. J Clin Oncol. 2025;43(Suppl 4). doi:10.1200/JCO.2025.43.4_suppl.633
22. Wang Y, Jin ZY. Radiomics approaches in gastric cancer: a frontier in clinical decision making. Chin Med J (Engl). 2019;132(16):1983-1989. doi:10.1097/CM9.0000000000000360
23. Yang L, Chu W, Li M, et al. Radiomics in gastric cancer: first clinical investigation to predict lymph vascular invasion and survival outcome using 18F-FDG PET/CT images. Front Oncol. 2022;12:836098. doi:10. 3389/fonc.2022.836098
24. Huang ZN, Zhang HX, Sun YQ, et al. Multi-cohort study in gastric cancer to develop CT-based radiomic models to predict pathological response to neoadjuvant immunotherapy. J Transl Med. 2025;23(1):362. doi:10.1186/s12967-025-06363-z
Article available in :
Volume 2, Issue 4, 2025
Page : 64-70
https://doi.org/10.51271/JRM-0037
Article Information
Received : 04 Ağu 2025
Accepted : 29 Eyl 2025
Published : 15 Eki 2025
Corresponding Author :

Görkem Özdemir: Department of Gastroenterological Surgery, Adana City Training and Research Hospital, Adana, Turkiye

[email protected]
Citation : Özdemir G, Tulu ÇN, Işık Ö, Ölmez T, Sözütek A. Integration of CT radiomics and clinical factors to predict pathological response to FLOT chemotherapy in gastric cancer. J Radiol Med. 2025;2(4):64-70.

Read: 146
Download : 769
Cited: 0
_Footer